P-73 BXQ-350: A phase 1b/2 placebo-controlled, double-blind study on the efficacy and safety of BXQ-350 in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma
Titel:
P-73 BXQ-350: A phase 1b/2 placebo-controlled, double-blind study on the efficacy and safety of BXQ-350 in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma
Auteur:
Patel, R. Chung, K. Flora, D. Fuloria, J. Sharma, V. Curry III, R. Gazda, M. Purvis, J. Tapolsky, G. Takigiku, R.